NDC Package 0069-0277-02 Doxorubicin Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory .

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-0277-02
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Doxorubicin Hydrochloride
Usage Information:
Doxorubicin Hydrochloride Injection/for Injection are contraindicated in patients with:Severe myocardial insufficiency [see Warnings and Precautions (5.1)]Recent (occurring within the past 4–6 weeks) myocardial infarction [see Warnings and Precautions (5.1)]Severe persistent drug-induced myelosuppression [see Warnings and Precautions (5.4)]Severe hepatic impairment (defined as Child Pugh Class C or serum bilirubin level greater than 5 mg/dL) [see Warnings and Precautions (5.5)]Severe hypersensitivity reaction to doxorubicin hydrochloride, including anaphylaxis [see Adverse Reactions (6.2)]
11-Digit NDC Billing Format:
00069027702
NDC to RxNorm Crosswalk:
  • RxCUI: 1191138 - DOXOrubicin HCl 2 MG/ML Injectable Solution
  • RxCUI: 1191138 - doxorubicin hydrochloride 2 MG/ML Injectable Solution
  • RxCUI: 1790097 - DOXOrubicin HCl 10 MG in 5 mL Injection
  • RxCUI: 1790097 - 5 ML doxorubicin hydrochloride 2 MG/ML Injection
  • RxCUI: 1790097 - doxorubicin hydrochloride 10 MG per 5 ML Injection
  • Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Sample Package:
    No
    FDA Application Number:
    NDA050629
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-09-2024
    End Marketing Date:
    05-09-2024
    Listing Expiration Date:
    05-09-2024
    Exclude Flag:
    D
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-0277-02?

    The NDC Packaged Code 0069-0277-02 is assigned to a package of 1 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose of Doxorubicin Hydrochloride, labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is and is administered via form.

    Is NDC 0069-0277 included in the NDC Directory?

    The product was first marketed by Pfizer Laboratories Div Pfizer Inc on May 09, 2024 and its listing in the NDC Directory is set to expire on May 09, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0069-0277-02?

    The 11-digit format is 00069027702. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-0277-025-4-200069-0277-02